TIGIT

Join Our Mission

The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”

TrialNet

ATG Preserves β-Cell Function in Clinical Trial

The 1-year C-peptide was significantly higher (β-cell preservation) in subjects treated with ATG versus placebo (P = 0.0003) but not in those treated with ATG/GCSF versus placebo (P = 0.031).

Figure 2

What’s your GRS?

The Brusko Lab and collaborators are trying to better understand how genes influence T1D risk

AI is Not Invisible

Autoimmune diseases are called “invisible diseases” as symptoms are not seen. AI is Not Invisible is trying to help bring awareness for the 80 autoimmune diseases that can affect us.

Our Research Focus

Our laboratory aims to harness the power of naturally occurring regulatory T cells to correct unwanted immune responses that deliver a cure for type 1 diabetes.

Peeps

Our Staff

From undergraduate students to post-doctoral fellows – every set of hands is important.

Prev Next

Contact Us

Discovery consists of seeing what everybody has seen and thinking what nobody has thought

-Albert Szent-Gyorgyi